Affordable Access

Rationale and design of the enoximone clinical trials program.

Authors
  • Lowes, Brian D
  • Shakar, Simon F
  • Metra, Marco
  • Feldman, Arthur M
  • Eichhorn, Eric
  • Freytag, J William
  • Gerber, Michael J
  • Liard, Jean-Francois
  • Hartman, Craig
  • Gorczynski, Rick
  • Evans, Gwyn
  • Linseman, Jennifer V
  • Stewart, Jennifer
  • Robertson, Alastair D
  • Roecker, Ellen B
  • Demets, David L
  • Bristow, Michael R
Type
Published Article
Journal
Journal of Cardiac Failure
Publisher
Elsevier
Publication Date
Dec 01, 2005
Volume
11
Issue
9
Pages
659–669
Identifiers
PMID: 16360960
Source
Medline
License
Unknown

Abstract

These studies are Phase III, multicenter, randomized, double-blinded, placebo-controlled trials designed to test the general hypothesis that chronic oral administration of low doses of enoximone can produce beneficial effects in subjects with advanced or ultra-advanced chronic heart failure.

Report this publication

Statistics

Seen <100 times